Clinical utility of TERT promoter mutations and ALK rearrangement in thyroid cancer patients with a high prevalence of the BRAF V600E mutation

BACKGROUND: Mutations in the TERT promoter, ALK rearrangement, and the BRAF V600E mutation are associated with aggressive clinicopathologic features in thyroid cancers. However, little is known about the impact of TERT promoter mutations and ALK rearrangement in thyroid cancer patients with a high p...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Diagn Pathol
Main Authors: Bae, Ja Seong, Kim, Yourha, Jeon, Sora, Kim, Se Hee, Kim, Tae Jung, Lee, Sohee, Kim, Min-Hee, Lim, Dong Jun, Lee, Youn Soo, Jung, Chan Kwon
Formato: Artigo
Idioma:Inglês
Publicado: BioMed Central 2016
Assuntos:
Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4746931/
https://ncbi.nlm.nih.gov/pubmed/26857243
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13000-016-0458-6
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares